Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jun 4;16(6):e61658.
doi: 10.7759/cureus.61658. eCollection 2024 Jun.

Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review

Affiliations
Review

Clinical Performance of Implant-Supported Prostheses in the Rehabilitation of Patients Previously Treated for Medication-Related Osteonecrosis of the Jaws (MRONJ): A Systematic Review

Eduardo Anitua et al. Cureus. .

Abstract

There is a lack of consensus on managing resultant bone and soft tissue defects or on restoring oral function and aesthetics following medication-related osteonecrosis of the jaws (MRONJ) lesion healing. This clinical challenge presents a dilemma for practitioners. Removable prostheses pose a recurrence risk if poorly fitted and may inadequately restore function or aesthetics in cases of significant bone defect. Dental implant-supported prostheses could enhance function and quality of life, though their risks and indications are not well-defined. This systematic review examines the clinical outcomes and complications associated with implant-supported rehabilitations post-MRONJ surgery. This study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement recommendations and it was pre-registered in the Prospective Register of Systematic Reviews (PROSPERO) (CRD42023492539).

Keywords: dental implants; dental prosthesis; implant-supported prosthesis; medication-related osteonecrosis of the jaw; systematic review.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: Eduardo Anitua Mohammad Hamdan Alkhraisat declare(s) employment from BTI Biotechnology Institute. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Study selection workflow
Study selection workflow diagram following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Similar articles

Cited by

References

    1. American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws-2022 update. Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. J Oral Maxillofac Surg. 2022;80:920–943. - PubMed
    1. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Nicolatou-Galitis O, Schiødt M, Mendes RA, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127:117–135. - PubMed
    1. Review and update on drugs related to the development of osteonecrosis of the jaw. Eguia A, Bagán-Debón L, Cardona F. Med Oral Patol Oral Cir Bucal. 2020;25:0–83. - PMC - PubMed
    1. Pathophysiology of medication-related osteonecrosis of the jaw-a minireview. Tetradis S, Allen MR, Ruggiero SL. JBMR Plus. 2023;7:0. - PMC - PubMed
    1. The effect of chronic dental inflammation on development of Stage 0 medication-related osteonecrosis of the jaw. Topaloglu G, Koseoglu OT, Karaca C, Kosemehmetoglu K. J Craniomaxillofac Surg. 2017;45:1158–1164. - PubMed

LinkOut - more resources